|
Name |
yanuthone D
|
| Molecular Formula | C28H38O8 | |
| IUPAC Name* |
5-[[(1S)-2,5-dioxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methoxy]-3-hydroxy-3-methyl-5-oxopentanoic acid
|
|
| SMILES |
CC(=CCC/C(=C/CC/C(=C/CC12[C@H](O1)C(=O)C(=CC2=O)COC(=O)CC(C)(CC(=O)O)O)/C)/C)C
|
|
| InChI |
InChI=1S/C28H38O8/c1-18(2)8-6-9-19(3)10-7-11-20(4)12-13-28-22(29)14-21(25(33)26(28)36-28)17-35-24(32)16-27(5,34)15-23(30)31/h8,10,12,14,26,34H,6-7,9,11,13,15-17H2,1-5H3,(H,30,31)/b19-10+,20-12+/t26-,27?,28?/m1/s1
|
|
| InChIKey |
NIBXHVDVUJEQPO-OFWAVEGMSA-N
|
|
| Synonyms |
yanuthone D
|
|
| CAS | NA | |
| PubChem CID | 139586902 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 502.6 | ALogp: | 3.8 |
| HBD: | 2 | HBA: | 8 |
| Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 131.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 36 | QED Weighted: | 0.198 |
| Caco-2 Permeability: | -5.358 | MDCK Permeability: | 0.00001540 |
| Pgp-inhibitor: | 0.065 | Pgp-substrate: | 0.842 |
| Human Intestinal Absorption (HIA): | 0.314 | 20% Bioavailability (F20%): | 0.011 |
| 30% Bioavailability (F30%): | 0.025 |
| Blood-Brain-Barrier Penetration (BBB): | 0.022 | Plasma Protein Binding (PPB): | 83.61% |
| Volume Distribution (VD): | 0.375 | Fu: | 11.81% |
| CYP1A2-inhibitor: | 0.007 | CYP1A2-substrate: | 0.065 |
| CYP2C19-inhibitor: | 0.067 | CYP2C19-substrate: | 0.172 |
| CYP2C9-inhibitor: | 0.189 | CYP2C9-substrate: | 0.962 |
| CYP2D6-inhibitor: | 0.027 | CYP2D6-substrate: | 0.041 |
| CYP3A4-inhibitor: | 0.183 | CYP3A4-substrate: | 0.165 |
| Clearance (CL): | 7.353 | Half-life (T1/2): | 0.72 |
| hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.655 |
| Drug-inuced Liver Injury (DILI): | 0.623 | AMES Toxicity: | 0.826 |
| Rat Oral Acute Toxicity: | 0.019 | Maximum Recommended Daily Dose: | 0.227 |
| Skin Sensitization: | 0.926 | Carcinogencity: | 0.221 |
| Eye Corrosion: | 0.106 | Eye Irritation: | 0.048 |
| Respiratory Toxicity: | 0.939 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003133 | ![]() |
0.743 | D09XWD | ![]() |
0.397 | ||
| ENC001464 | ![]() |
0.423 | D05XQE | ![]() |
0.389 | ||
| ENC006119 | ![]() |
0.410 | D03VFL | ![]() |
0.367 | ||
| ENC001465 | ![]() |
0.410 | D01ZUA | ![]() |
0.239 | ||
| ENC001466 | ![]() |
0.410 | D06BLQ | ![]() |
0.219 | ||
| ENC001716 | ![]() |
0.404 | D09ANG | ![]() |
0.204 | ||
| ENC001096 | ![]() |
0.386 | D0X7XG | ![]() |
0.202 | ||
| ENC001462 | ![]() |
0.386 | D0ZI4H | ![]() |
0.197 | ||
| ENC004068 | ![]() |
0.374 | D04FBR | ![]() |
0.187 | ||
| ENC003494 | ![]() |
0.364 | D03JSJ | ![]() |
0.184 | ||